<DOC>
	<DOC>NCT00215371</DOC>
	<brief_summary>The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control group.</brief_summary>
	<brief_title>Study in Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Require the regular use of an inhaled beta2selective adrenergic agent. No clinically significant abnormalities on the medical history, physical examination, and clinical laboratory tests. Active acute or chronic disorders of the respiratory system within one month prior to screening. Smoking history within the past 12 months or greater than a lifetime 10 packyear smoking history. Debilitating systemic and/or lifethreatening diseases.</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Formoterol Fumarate</keyword>
	<keyword>Foradil</keyword>
</DOC>